Voyager Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

LEXINGTON, Mass., July 09, 2024 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to advancing neurogenetic medicines, has entered into an employment agreement with Nathan Jorgensen, Ph.D., M.B.A. that, among other things, provides for the grant to Dr. Jorgensen of a non-qualified stock option and restricted stock units as an inducement material to Dr. Jorgensen’s entering into employment with Voyager. The inducement awards were approved by the Compensation Committee of Voyager’s Board of Directors in accordance with Nasdaq Stock Market Listing Rule 5635(c)(4). The option award became effective on July 8, 2024, and the restricted stock unit award is scheduled to become effective on October 1, 2024.

Read more at globenewswire.com